Clinical Topics & News

Generalized Pustular Psoriasis of Zambusch: Case Report of Successful Disease Control With Cyclosporine and Etanercept

Author and Disclosure Information

Generalized pustular psoriasis of Zambusch is a unique and challenging skin condition to successfully manage. Patients often encounter potentially high recurrence rates of pustular eruptions despite multidrug treatment regimens with high morbidity as a consequence. We report a case of generalized pustular psoriasis of Zambusch in a patient whose disease initially flared following early treatment with the anti–tumor necrosis factor α (anti–TNF-α) inhibitor etanercept but was later successfully managed with cyclosporine and reintroduction of etanercept. We also discuss therapeutic management options for generalized pustular psoriasis.


 

Recommended Reading

Meta-Analysis Shows 75% Increased Risk Herpes Zoster With Anti-TNF
MDedge Dermatology
Clinical Trials May Overestimate Benefits of Psoriasis Drugs
MDedge Dermatology
Lupus Severity May Contribute Significantly to Heart Damage
MDedge Dermatology
Genotypes in ANCA-Associated Vasculitis May Guide Therapy
MDedge Dermatology
Subclinical Enthesitis Is More Common in Psoriatic Arthritis
MDedge Dermatology
Collagenase Might Be a First-Line Treatment for Dupuytren's Contractures
MDedge Dermatology
Most Psoriasis Patients at Risk for Heart Disease
MDedge Dermatology
Systemic Psoriasis Therapies Cut MI Risk
MDedge Dermatology
Rheumatologic Serologies Can Be a Confounding Quagmire
MDedge Dermatology
Use of Bovine-Based Collagen Ointment in the Treatment of Plaque Psoriasis: An Open-Label, Pilot, Observational Clinical Study of 12 Patients
MDedge Dermatology